Refereed Journal Articles
2009
Clement F, Harris A, Li JJ, Yong K, Braden M, Manns J. Using effectiveness and cost-effectiveness to make drug coverage decisions. A comparison of Britain, Australia, and Canada. JAMA: 2009;302(13):1437-1443.
Hollingsworth B and Richardson J. A conceptual model of the economic impact of international movements in the health labour force. Applied Economic Letters, 2009; 16:609-613.
Jha R, Gaiha R & Sharma A. Calorie and Micronutrient Deprivation and Poverty Nutrition Traps in Rural India. World Development, 2009: 37(5); 982-991.
Jha R, Gaiha R, Sharma A. Mean Consumption, Poverty and Inequality in Rural India in the Sixtieth Round of the National Sample Survey *Accepted */Journal of Asian and African Studies/
McKie J, Shrimpton B, Richardson J and Hurworth R, Treatment costs and priority setting in health care: A qualitative study, Australia and New Zealand Health Policy, 2009: 6:11.
Morris M, Watts J, Iansek R, Jolley D, Campbell D, Murphy A, Martin C. Quantifying the profile and progression of impairments, activity, participation, and quality of life in people with Parkinson disease; protocol for a prospective cohort study. BMC Geriatrics 2009; 9(2):1-6.
Mortimer D, Segal L, Sturm J. Can we derive an 'exchange rate' between descriptive and preference-based outcome measures for stroke? Results from the transfer to utility (TTU) technique. Health and Quality of Life Outcomes 2009, 7:33 doi:10.1186/1477-7525-7-33
Ramful P & Zhao X. Participation in marijuana, cocaine and heroin consumption in Australia: a multivariate probit approach. Applied Economics; 2009, 41: 481-496. (URL:
Richardson J, Peacock S, Iezzi A. Do quality-adjusted life years take account of lost income? Evidence from an Australian survey. The European Journal of Health Economics 2009 10:103-109.
Richardson J. Is the incorporation of equity considerations into economic evaluations really so simple? A comment on Cookson, Drummond and Weatherly. Health Economics Policy and Law 2009 4: 247-254.
Segal L, Dalziel K, Mortimer D. Fixing the game: are between-silo differences in funding arrangements handicapping some interventions and giving others a head-start? Health Economics, Published Online: Apr 20 2009 4:14AM DOI: 10.1002/hec.1483
Spinks J & Hollingsworth B, Are the economics of complementary and alternative medicine different to conventional medicine? Expert Review of Pharmacoeconomics & Outcome Research: 2009 9(1):1-4
Spinks J & Hollingsworth B. Cross country comparisons of technical efficiency of health production: a demonstration of pitfalls. Applied Economics: 2009:41:4: 417-427.
Watts J, Segal L. Market failure, policy failure and other distortions in chronic disease markets
BMC Health Services Research 2009, 9:102
Wildman J, Hollingsworth B. Blood donation and the nature of altruism. Journal of Health Economics, 2009:28;492-503. (URL:
Zhang X, Zhao X. & Harris, A. Chronic Diseases and Labour Market Participation in Australia. Journal of Health Economics: 2009 (28): 91–108.
2008
Dalziel K, Segal L, Mortimer D. Review of Australian health economic evaluation – 245 interventions: what can we say about cost-effectiveness? Cost Effectiveness and Resource Allocation; 2008, 6:9 doi:10.1186/1478-7547-6-9
Harris A, Hill S, Chin G, Li JJ, Walkom E. The role of value for money in public insurance coverage decisions for drugs in Australia. A retrospective analysis 1994-2004. Medical Decision Making. (in press: accepted Jan 2008) (IF=1.736)doi:10.1177/0272989x08315247
Hawthorne G, Densley K, Pallant J, Mortimer D, Segal L. Deriving utility scores from the SF-36 health instrument using Rasch analysis. Quality of Life Research 2008; 17: 1183-1193
Hollingsworth B, Harris A, Mortimer D. The cost effectiveness of intracyctoplasmic sperm injection (ICSI). Journal of Assisted Reproduction and Genetics 2008; 24: 571-577.
Hollingsworth B. The measurement of efficiency and productivity of health care delivery. Health Economics 2008, 17:1107-1128. doi: 10.1002/hec.1391
McKenzie J, French S, O’Connor D, Grimshaw J, Mortimer D, Michie S, Francis J, Spike N, Schattner P, Kent P, Buchbinder R, Green S. IMPLEmenting a clinical practice guideline for acute low back pain evidence-based management in general practice (IMPLEMENT): cluster randomised controlled trial study protocol. Implementation Science 2008, 3:11
McKie J, Shrimpton B, Hurworth R, Bell C, Richardson J 2008 'Who Should Be Involved in Health Care Decision Making? A Qualitative Study’, Health Care Analysis, vol 16 no 2 pp 114-126.
Mortimer D, French S, McKenzie J, O’Connor D, Green S. Protocol for economic evaluation alongside the IMPLEMENT cluster randomised controlled trial. Implementation Science 2008, 3:12
Mortimer D. Modelling Downstream Effects in the Presence of Technological Change, PharmcoEconomics 2008, 26:12; 991-1003 (ISI IF: 2.623).
Mortimer D & Segal L Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-Weights. Medical Decision Making. 2008; 28: 66-89. Online version: http://mdm.sagepub.com/cgi/content/abstract/28/1/66
Mortimer D & Segal L. Is the value of a life or life-year saved context specific? Further evidence from a discrete choice experiment. Cost Effectiveness and Resource Allocation; 2008, 6:8 doi:10.1186/1478-7547-6-8
Peacock S, Misajon R, Iezzi A, Richardson J, Hawthorne G, Keeffe J. Vision and Quality of Life: Development of methods for the VisQol Vision-Related Utility Instrument. Ophthalmic Epidemiology 2008; 15:218-223.
Ramful P& Zhao X. Heterogeneity in Alcohol Consumption: The Case of Beer, Wine and Spirits in Australia. Economic Record 2008; 84(265): 207-222.
Richardson J & McKie J.Increasing the options for reducing adverse events: Results from a modified Delphi technique. Australia and New Zealand Health Policy 2008, 5:25 (accepted 14 Nov 2008
Richardson J, Peacock S, Iezzi A. Do quality adjusted life years take account of lost income? Evidence from an Australian survey. Eur J Health Econ DOI 10.1007/s10198-008-0107-4
Shrimpton B, McKie J, Hurworth R, Bell C, Richardson J. Health Care Decision-Making: A focus group study involving health professional and the general public. Qualitative Research Journal 2008; 8(2):
Watts J & Segal L. Vouchers for chronic disease care. Australian Health Review 2008; 32(3): 451 – 458.
Watts J, McGinley J, Huxham F, Menz H, Iansek R, Murphy A, Waller E, Morris M. Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial. BMC Geriatrics 2008, 8(23): doi:10.1186/1471-2318-8-23
Zhang X, Zhao X, Harris A. Chronic diseases and labour force participation in Australia. Journal of Health Economics 2008: 28; 91-108
McKie J, Shrimpton B, Hurworth R, Bell C, Richardson J, Who should be involved in health care decision making? A qualitative study, Health Care Analysis2008
Mortimer, D, Segal, L. Comparing the incomparable? A systematic review of competing techniques for mapping one health outcome measure into another. Medical Decision Making. 2008
2007
Bennell K, Coburn S, Wee E, Green S, Harris A, Forbes A, Buchbinder R. Efficacy and cost-effectiveness of a physiotherapy program for chronic rotator cuff pathology: A protocol for a randomised, double-blind, placebo-controlled trial. BMC Musculoskeletal Disorders; 2007, 8:86
Buchbinder R, Youd J, Green S, Stein A Forbes A, Harris AH, Bennell K, Bell S, Wright WLJ. Efficacy and cost-effectiveness of physiotherapy following glenohumeral joint distension for adhesive capsulitis: A randomized trial. Arthritis Care Research 2007;57:1027-103
Busija L, Hollingsworth B, Buchbinder R, Osborne R. Role of age, sex, and obesity in the higher prevalence of arthritis among lower socioeconomic groups: a population-based survey. Arthritis & Rheumatism (Arthritis Care and Research; 2007 57:4 553-561.
Dalziel K, Segal L. Time to give nutrition interventions a higher profile: cost effectiveness of 10 nutrition interventions. Health Promotion International.
Harris A. The organization and funding of the treatment of end-stage renal disease in Australia. International Journal of Health Financing and Economics: 2007; 7:113-132
Harvey K, Harris AH, Bulfone L. The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: Reform or fracture? The Medical Journal of Australia, 2007; 187(4):206-207
Hauck K, Street A . Do targets matter? A comparison of English and Welsh national health priorities. Health Economics, (forthcoming).
Hollingsworth B, Richardson J. (forthcoming) A conceptual model of the economic impact of international movements in the health labour force, Applied Economics Letters (accepted January 2007).
Mortimer D, Segal L, Hawthorne G & Harris A. Item-based versus scale-based mappings from the SF36 to a preference-based quality of life measure. Value in Health. 2007: 10(5).
Peacock S, Richardson J, Carter R, Edwards D. Priority setting in health care using multi-attribute utility theory and program budgeting and marginal analysis (PBMA), Social Science and Medicine, 2007 64:4 897-910
Peacock S, Ruta D, Mitton C, Donaldson C, Bate A, Murtagh M. 'Using economics for pragmatic and ethical priority setting: two checklists for doctors and managers', British Medical Journal, (in press).
Richardson J, McKie J. Economic evaluation of services for a National Health Scheme: The case for a fairness-based framework, Journal of Health Economics; 2007 26: 785-799.
Spinks J & Hollingsworth B. Cross country comparisons of technical efficiency of health production: a demonstration of pitfalls. Applied Economics, (forthcoming)
Tiong A, Vu T, Counahan M, Leydon J, Tallis G, and Lambert S, 2007, Multiple sites of exposure in an outbreak of ornithosis in workers at a poultry abattoir and farm. Epidemiology and Infection
Vu T, Harris A, Duncan G, Sussman G. Cost-effectiveness of multidisciplinary wound care in nursing homes: a pseudo-randomised pragmatic cluster trial. Family Practice: 2007 24: 372-379
Watson W, Ozanne-Smith J, Richardson J. Retrospective baseline measurement of self-reported health status and health-related quality of life versus population norms in the evaluation of post-injury losses: A validation, Injury Prevention; 2007:13, 45-50.
2006
Apicella C, Peacock S, Andrews L, Daly M, Tucker K, Bankier A, Hopper J. Determinants of preferences for genetic counselling in Jewish women. Familial Cancer, 5: 159-167.
Busjia L, Hollingsworth B, Buchbinder R, Osborne R. Age, gender and obesity explained higher prevalence of arthritis among lower SES groups in a population-based survey. Arthritis Care and Research, (forthcoming).
Dalziel K, Segal L, Elley R. Cost utility analysis of physical activity counselling in general practice. Australian and New Zealand Journal of Public Health, 30(1):57-63.
Dalziel K, Segal L, de Lorgeril M. A Mediterranean diet is cost-effective in patients with previous myocardial infarction. Journal of Nutrition, 136: 1879-1885.
Dalziel K, Segal L. An Uncertainty in economic analysis of school based obesity prevention programs. Obesity Research, (in press).
Ehsani J, Vu T, Karvelas M. Exploring the need for hepatology nurses and allied health professionals in Victorian liver clinics. Australian Health Review, 3(2):211-218.
Gospodarevskaya E, Goergen S, Harris A, et al. Economic evaluation of a clinical protocol for diagnosing emergency patients with suspected pulmonary embolism. Cost Effectiveness and Resource Allocation, 4:12.
Harris M, Ramful P, Zhao X. Alcohol consumption in Australia : An application of the OGEV model to micro-unit data. Journal of Health Economics, 25 (4): 782-801.
Hollingsworth B, Street A. The market for efficiency analysis of health care organisations. Health Economics 15: 1055-1059.
McDermott R, Segal L. Cost impact of improved primary level diabetes care in remote Australian Indigenous communities Australian Journal of Primary Health, (in press).
Moodie R, Swinburn B, Richardson J, Somaini B. Childhood obesity – a sign of commercial success, but a market failure, International Journal of Paediatric Obesity, 1(3): 133-138.
Mortimer D, French S. Can dissenting findings with respect to the comparative effectiveness of ICSI and IVF be explained by a learning curve? Journal of Assisted Reproduction & Genetics, 23(1):33-36.
Mortimer D, Segal L . Economic evaluation of interventions for problem drinking and alcohol dependence: Do within-family external effects make a difference? Alcohol & Alcoholism, 41(1):92-98.
Mortimer D. On the social value of thinly-spread QALYs. Pharmacoeconomics, (in press).
Mortimer D, Kelly J. Economic evaluation of the Good Life Club intervention for diabetes self-management. Australian Journal of Primary Health, 12 (1): 91 - 100.
Peacock S, Ruta D, Mitton C, Donaldson C, Bate A, Murtagh M. Using economics for pragmatic and ethical priority setting: two checklists for doctors and managers, British Medical Journal, (in press).
Sanders K, Nicholson G, Watts J, Pasco J, Henry M, Kotowicz M, Seeman E. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost effective? Bone, 38: 694-700.
Richardson J, Abel Olsen J. In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'. Health Economics, 15:311-313.
Richardson J, Peacock S, Mortimer D. Does an increase in the doctor supply reduce medical fees? An econometric analysis of medical fees across Australia . Applied Economics, 38:253-266.
Richardson J, Peacock S. Supplier-Induced Demand. Reconsidering the theories and new Australian evidence. Applied Economics and Health Policy, 5 (2):87-98.
Segal L, Mortimer D. A population-based model for priority setting across the care continuum and across modalities. Cost Effectiveness and Resource Allocation, 4:6.
Spinks J, Hollingsworth B. Cross country comparisons of technical efficiency of health production: a demonstration of pitfalls. Applied Economics, (forthcoming).
Whitfield K, Buchbinder R, Segal L, Osborne R. Parsimonious and efficient assessment of health-related quality of life in osteoarthritis: validation of the Assessment of Quality of Life (AQoL) instrument, Health and Quality of Life Outcomes, 4 (19).
Zhang Y, Zhao X. Love of variety and scale implications: An empirical evaluation, Division of Labour and Transaction Costs, Vol 1 (2): 185-201.
2005
Dalziel K, Round A, Garside R, et al. Cost effectiveness of imatinib compared with interferon- a or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia. Pharmacoeconomics 23(5):515-526.
Dalziel K, Round A, Stein K, et al. Do the findings of case series studies vary significantly according to methodological characteristics? Health Technology Assessment 9(2).
Harris A, Gospodarevskaya E. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics 23(1):77-91.
Henry A, Hill S, Harris A. Drug prices and value for money: The Australian Pharmaceutical Benefits Scheme. The Journal of the American Medical Association 294 (20): 2630-2632.
Kelly H, Vu T, Smith D. Influenza vaccination and mortality in the US. Archives of Internal Medicine 165(17):2037-a-2038.
Misajon R, Hawthorne G, Richardson J, Barton J, Peacock S, Iezzi A, Keeffe J. Vision and quality of life: the development of a utility measure. Investigative Ophthalmology & Visual Science 46 (11): 4007-4015.
Moore DS, Shiell A, Hawe P, et al. The privileging of communitarian ideas: citation practices and the translation of social capital into public health research. American Journal of Public Health 95(8):1330-1337.
Moore DS, Shiell A, Haines V, et al. Contextualizing and assessing the social capital of seniors in congregate housing residences: study design and methods. BMC Public Health 5:38.
Mortimer D. On the relevance of personal characteristics in setting health priorities: a comment on Olsen, Richardson, Dolan and Menzel (2003). Social Science and Medicine 60:1661-1664.
Mortimer D, Segal L. Economic evaluation of interventions for problem drinking and alcohol dependence: cost per QALY estimates. Alcohol and Alcoholism 40(6):549-555.
Richardson J. Priorities of health policy: cost shifting or population health. Australia & New Zealand Health Policy 2(1).
Richardson J, McKie J. Empiricism, ethics and orthodox economic theory: what is the appropriate basis for decision-making in the health sector? Social Science and Medicine 60:265-275.
Riley T, Hawe P, Shiell A. Contested ground: how should qualitative evidence inform the conduct of a community intervention trial? Journal of Health Services Research and Policy 10(2):103-110.
RoseAnne M, Hawthorne G, Richardson J, Barton J, Peacock S, Iezzi A, Keeffe J. Vision and quality of life: the development of a utility measure. Investigative Ophthalmology & Visual Science 46(11):4007-4015.
Smith R, Richardson J. Can we estimate the 'social' value of QALY? Four core issues to resolve. Health Policy 74:77-84.
Stein K, Dalziel K, Garside R, et al. Association between methodological characteristics and outcome in health technology assessments which included case series. International Journal of Technology Assessment in Health Care 21(3):277-287.
Watson W, Ozanne-Smith J, Richardson J. An evaluation of the Assessment of Quality of Life utility instrument as a measure of the impact of injury on health-related quality of life. International Journal of Injury Control and Safety Promotion 12(4):227-239.
2004
Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Dempster J, Fraenkel MB, Harris A, et al. The initiating dialysis early and late (IDEAL) study: study rationale and design. Peritoneal Dialysis International 24(2):176-181.
Dalziel K, Round A, Stein K, et al. Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. Health Technology Assessment 8(28).
Harris A. The cost effectiveness of prenatal ultrasound screening for trisomy 21. International Journal of Technology Assessment in Health Care 20(4):464-468.
Hawe P, Riley T, Shiell A. Complex interventions: how "out of control" can a randomised controlled trial be? British Medical Journal 328:1561-1563.
Hawe P, Shiell A, Riley T, et al. Methods for exploring implementation variation and local context within a cluster randomised community intervention trial. Journal of Epidemiology and Community Health 58(9):788-793.
Hawe P, Webster C, Shiell A. A glossary of terms for navigating the field of social network analysis. Journal of Epidemiology and Community Health 58(12):971-975.
Hollingsworth B, Wildman J. What population factors influence the decision to donate blood? Transfusion Medicine 14:9-12.
Hollingsworth B. Non parametric efficiency measurement. The Economic Journal 114:F307-F311.
Peacock S, Pirkis J, et al. Health services research, policy and practice in Australia and New Zealand : a coming of age - editorial. Journal of Heatlh Services Research and Policy 9 (Suppl 2):S2:1-S2:2.
Richardson J, Day N, Peacock S, Iezzi A. Measurement of the quality of life for economic evaluation and the Assessment of Quality of Life (AQoL) Mark 2 Instrument. The Australian Economic Review 37(1):62-88.
Richardson J, Segal L. Private health insurance and the Pharmaceutical Benefits Scheme: how effective has recent government policy been? Australian Health Review 28(1):34-47.
Rush B, Shiell A, Hawe P. A census of economic evaluations in health promotion. Health Education Research 19(6):707-719.
Segal L. Health insurance - universal cover or a safety-net? A critique. Economic Papers 23(2):114-128.
Segal L. Why it is time to review the role of private health insurance in Australia . Australian Health Review 27(1):3-15.
Segal L, S Day, Chapman A, Osborne R. Can we reduce disease burden from osteoarthritis? An evidence-based priority-setting model. Medical Journal of Australia 180:S11-S17.
Segal L, Dunt D, Day SE, Day N, Robertson I, Hawthorne G. Introducing co-ordinated care (1): a randomised trial assessing client and cost outcomes. Health Policy 69:201-213.
Segal L, Dunt D, Day SE. Introducing co-ordinated care (2): evaluation of design features and implementation processes implications for a preferred health system reform model. Health Policy 69:215-228.
Vu T, Harris A, Gospodarevskaya E. Creutzfeld-Jakob disease: a review of current knowledge. Victorian Infectious Diseases Bulletin 7(1):2-5.
Vu T, Harris A, Gospodarevskaya E. Improved infection control in the preventionof variant Creutzfeldt-Jakob disease in Australia: costs and benefits. Australian and New Zealand Journal of Public Health 28(6):57-64.
2003
Hellard ME, Sinclair MI, Harris A, Kirk M, Fairley CK. Cost of community gastroenteritis. Journal of Gastroenterology and Hepatology 18:322-328.
Hollingsworth B. Non-parametric and parametric applications measuring efficiency in health care. Health Care Management Science 6(4):203-218.
Hollingsworth B, Harris A. The economic consequences of introducing deep brain stimulation for the treatment of advanced Parkinson's disease in Australia. Australasian Journal of Ageing 22(3):127-130.
Hollingsworth B, Parkin D. Efficiency and productivity change in the English National Heatlh Service: can data envelopment analysis provide a robust and useful measure? Journal of Heatlh Services Research and Policy 8(4):230-236.
Hollingsworth B, Smith P. Use of ratios in data envelopment analysis. Applied Economic Letters 10:733-735.
Hollingsworth B, Wildman J. The efficiency of health production: re-estimating the WHO panel data using parametric and non-parametric approaches to provide additional information. Health Economics 12:493-504.
Kermode M, Harris A, Gospodarevskaya E. Introducing retractable needles into needle and syringe programmes: a review of the issues. International Journal of Drug Policy 14(2):233-239.
McKie J, Richardson J. The rule of rescue. Social Science and Medicine 52(12):2407-2419.
Mitton C, Peacock S, Donaldson C, Bate A. Using PBMA in health care priority setting: description, challenges and experience. Applied Health Economics and Health Policy 2(3):121-134.
Olsen J, Richardson J, Dolan P, Menzel P. The moral relevance of personal characteristics in setting health care priorities. Social Science and Medicine 57:1163-1172.
Richardson J, Wildman J, Robertson I. A critique of the World Health Organisation's evaluation of health system performance. Health Economics 12:355-366.
Shiell A, Rush B. Can willingness to pay capture the value of altruism? An exploration of Sen's notion of commitment. Journal of Socio-Economics 32(6):647-660.
Shiell A, Hawe P, Fletcher M. Reliability of health utility measures and a test of values clarification. Social Science and Medicine 56(7):1531-1541.
Shiell A, Gold L. If the price is right: vagueness and values clarification in contingent valuation. Health Economics 12(11):909-919.
2002
Gravelle H, Wildman J, Sutton M. Income, income inequality and health: what can we learn from aggregate data? Social Science and Medicine 54:577-589.
Harris A, Osborne R, Streeton C, McNeil H. Quality of life and Kaposi sarcoma: using preference techniques to value the health gains from treatment. Support Care Cancer 10:486-493.
Hollingsworth B, Harris A, Gospodarevskaya E. The efficiency of immunization of infants by local government. Applied Economics 34:2341-2345.
Rychetnik L, Frommer M, Shiell A, et al. Criteria for evaluating evidence on public health interventions. (theory and methods). Journal of Epidemiology and Community Health 56(2):119-127.
Segal L, Donato R, Richardson J, Peacock S. Strengths and limitations of competitive versus non-competitive models of integrated capitated fundholding. Journal of Heatlh Services Research and Policy 7(Suppl 1):56-64.
Segal L, John S. The use of dermagraft in neuropathic foot ulcers in people with diabetes: an economic analysis in Australia. Primary Intention 10(2):49-57.
Shiell A, Seymour J. Preferences for public health insurance: egotism or altruism? International Journal of Social Economics 29(5):356-369.
Shiell A, Gold L. Contingent valuation in health care and the persistence of embedding effects without the warm glow. Journal of Economic Psychology 23(2):251-262.
Shiell A, Donaldson C, Mitton C, et al. Health economic evaluation: a glossary is presented on terms of health economic evaluation. Definitions are suggested for the more common concepts and terms. (glossary). Journal of Epidemiology and Community Health 56(2):85-88.
Ubel P, Richardson J, Baron J. Exploring the role of order effects in person trade-off elicitations. Health Policy 61:189-199.
2001
Duckett S, Jackson T. Paying for hospital emergency care under a single-payer system. Annals of Emergency Medicine 37 (3):309-317.
George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics 19(11):1-8.
Harris A. Economics, competition and the regulation of public health risks. Australian and New Zealand Journal of Public Health 25(1):41-43.
Harris A, Buxton M, O'Brien B, Rutten F, Drummond M. Using economic evidence in reimbursement decisions for health technologies: experience of four countries. Expert Review of Pharmacoeconomic Outcomes 1(1):89-94.
Harris A, Gospodarevskaya E, Callaghan J, Story I. The cost effectiveness of a pharmacist reviewing medication among the elderly in the community. Australasian Journal of Ageing 20(4):179-186.
Harris A, Yong K, Kermode M. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness. Australian and New Zealand Journal of Public Health 25(3):222-229.
Hawthorne G, Richardson J. Measuring the value of program outcomes: a review of multiattribute utility measures. Expert Review of Pharmacoeconomic Outcomes 1(2):215-228.
Hawthorne G, Richardson J, Day N. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Annals of Medicine 33(5):358-370.
Hollingsworth B. Health economics resources: current developments. HEPAC 2:31-32.
Jackson T. Rationing versus rationality: observations from outside the United States. Medical Decision Making 21:324-328.
Jackson T. Using computerised patient-level costing data for setting DRG weights: the Victorian (Australia) cost weight studies. Health Policy 56:149-163.
Richardson J. Supply and demand for medical care: or, is the health care market perverse? The Australian Economic Review 34(3):336-352.
Shiell A, Law MG. The costs of hepatitis C and the cost-effectiveness of its prevention. Health Policy 58(2):121-131.
Technological Change in Health Care (TECH) Research Network. Technological change around the world: evidence From heart attack care. Health Affairs 20(3):25-42.
Wildman J. The impact of income inequality on individual and societal health: absolute income, relative income and statistical artefacts. Health Economics 10:357-361.
Wutzke SE, Shiell A, Gomel MK, et al. Cost effectiveness of a brief intervention for reducing alcohol consumption. Social Science and Medicine 52(6):863-870.
2000
Duckett SJ, Jackson T. The new health insurance rebate: an inefficient way of assisting public hospitals. Medical Journal of Australia 172:439-442.
Hawe P, Shiell A. Social capital and health promotion: a review. Social Science and Medicine 51(6):871-875.
Jackson T. Cost estimates for inpatient care in Australia : evaluation of alternative sources. Australian and New Zealand Journal of Public Health 24(3):234-241.
Jackson T, Myles P. Part 2: total episode costs in a randomized, controlled trial of the effectiveness of four anesthetics. Anesthesia & Analgesia 91:1170-1175.
Kenny P, King M, Shiell A, et al. Early stage breast cancer: costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy. The Breast 9(1):37-44.
King M, Kenny P, Shiell A, et al. Quality of life three months and one year after first treatment for early stage breast cancer: influence of treatment and patient characteristics. Quality of Life Research 9(7):789-800.
Larcos G, Chi KKG, Shiell A, et al. Suspected acute pulmonary emboli: cost-effectiveness of chest helical computed tomography versus a standard diagnostic algorithm incorporating ventilation-perfusion scintigraphy. Australian and New Zealand Journal of Medicine 30(2):195-201.
Myles P, Hunt J, Fletcher H, Smart J, Jackson T. Part 1: propofol, thiopental, sevoflurane and isofluran - a randomized, controlled trial of effectiveness. Anesthesia & Analgesia 91:1163-1169.
Peacock S, Segal L. Capitation funding in Australia: imperatives and impediments. Health Care Management Science 3:77-88.
Robertson I, Richardson J. Coronary angiography and coronaryy artery revascularisation rates in public and private hospital patients after acute myocardial infarction. Medical Journal of Australia 173:291-295.
Scotton R. Medibank: from conception to delivery and beyond. Medical Journal of Australia 173:9-11.
Scotton R. Medicare: options for the next 25 years. Medical Journal of Australia 173:41-43.
Scotton R. Milestones on the road to Medibank and Medicare. Medical Journal of Australia 173:5-7.
Shiell A, Chapman S. The inertia of self-regulation: a game-theoretic approach to reducing passive smoking in restaurants. Social Science and Medicine 51(7):1111-1119.
Shiell A, Seymour J, Hawe P. Will our understanding of completeness ever be complete? Health Economics 9(8):729-731.
Shiell A, Seymour J, Hawe P, et al. Are preferences for health states complete? Health Economics 9(1):47-56.
Ubel P, Nord E, Gold M, Menzel P, Pinto Prades J, Richardson J. Improving value measurement in cost-effectiveness analysis. Medical Care 38(9):892-901.
Ubel P, Richardson J, Menzel P. Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis. Health Economics 9:127-136.
1999
Carlin J, Jackson T, Lane L, Bishop R, Barnes G. Cost effectiveness of rotavirus vaccination in Australia. Australian and New Zealand Journal of Public Health 23(6):611-616.
Carter R, Hailey D. Economic evaluation of the cochlear implant. International Journal of Technology Assessment in Health Care 15(3):520-530.
Carter R, Marks R, Hill D. Could a national skin cancer primary prevention campaign in Australia be worthwhile?: an economic perspective. Health Promotion International 14(No 1):73-82.
Defina J, Crowley S, Streeton C. Pharmacoepidemiology: a commentary on the evidence-based review of drug efficacy and safety. Australian Epidemiologist 6(2):5-9.
Hawthorne G, Richardson J, Osborne R. 'The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health related quality of life. Quality of Life Research 8:209-224.
Jackson T, Watts J, Lane L, Wilson R. Data comparability in patient level clinical costing systems. Casemix 1(No 1):36-45.
Menzel P, Gold M, Nord E, Pinto-Prades JL, Richardson J, Ubel P. Toward a broader view of values in cost-effectiveness analysis of health. Hastings Centre Report 29(3):7-15.
Mihalopoulos C, McGorry P, Carter R. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome? ACTA Psychatrica Scandinavica 54:1-9.
Nord E, Pinto-Prades JL, Richardson J, Menzel P, Ubel P. Incorporating societal concerns for fairness in numerical valuation of health programmes. Health Economics 8:25-39.
Olsen J, Richardson J. Production gains from health care: what should be included in cost-effective analyses? Social Science and Medicine 49:17-26.
Richardson J, Segal L. The cost of good health: how much will we need to spend? Journal of Law and Medicine 7(2):117-129.
Scotton R. Managed competition: the policy context. Australian Health Review 22(2):103-121.
Ubel P, Richardson J, Pinto-Prades JL. Life-saving treatments and disabilities. Are all QALYs created equal. International Journal of Technology Assesment in Health Care 15(4):738-748.
1998
Coast R, Smith R, Millar M. An economic perspective on policy to reduce antimicrobial resistance. Social Science and Medicine 46(1):29-38.
Cohen J, Piterman L, McCall L, Segal L. Near patient testing for serum cholesterol: attitudes of general practitioners and patients, appropriateness and costs. The Medical Journal of Australia 168(12):605-609.
Cohen J, Piterman L, McCall LM, Segal L. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. Health Promotion International 13(3):197-209.
Easton J, Segal L. Opportunistic screening for diabetes. Medical Journal of Australia 168:45.
Peacock S. Fundamental funding. Hospital & Healthcare (December):18-19.
Richardson J. Economic evaluation of health promotion: friend or foe? Australian and New Zealand Journal of Public health 22(2):247-253.
Robertson I, Bound R, Segal L. Colorectal cancer, diet and lifestyle factors: opportunities for prevention. Health Promotion International 13(2):141-150.
Schulman K, Burke J, Drummond M, Davies L, Carlsson P, Gruger J, Harris A, Lucioni C, Gisbert R, Llana T, Tom E, Bloom B, Willke R, Glick H. Resource costing for multinational neurological clinical trials: methods and results. Health Economics 7:629-638.
Segal L. Book review, economic evaluation of health promotion by C Phillips. Health Promotion International 13(2).
Segal L. Economic evaluation and health promotion. Health Promotion International 13(2):1-2.
Segal L. Health funding: the nature of distortions and implications for the health service mix. Australian and New Zealand Journal of Public Health 22(2):271-273.
Segal L. The importance of patient empowerment in health system reform. Health Policy 44:31-44.
Segal L, Dalton A, J. Richardson. Cost effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. Health Promotion International 13(3):197-209.
Smith R, Coast J. Controlling antimicrobial resistance: a proposed transferable permit market. Health Policy 43:219-232.
Smith R, Widiatmoko D. The cost-effectiveness of home assessment and modification to reduce falls in the elderly. Australian and New Zealand Journal of Public Health 22(4):436-440.
Smith R, Wilton P. General practice fundholding: progress to date. British Journal of General Practice 48:1253-1257.
Stewart M, Hailey D. Laser treatment for superficial vascular lesions in a public hospital program. Minimally Invasive Therapy and Allied Technologies 7:1653-1662.
Streeton C, Harris A. Treatment patterns of external genital warts in Australian general practice, 1997. Venereology 11(3):20-25.
Watts J, Jackson T. A task-weighted approach to determining authorship. Australian Journal of Primary Health Interchange 4(2):64-70.
Wilton P, Smith R. Primary care reform: a three country comparison of budget holding. Health Policy 44:149-166.
1997
Carr-Hill R, Hardman G, Martin S, Peacock S, Sheldon T, Smith P. A new formula for distributing hospital funds in England. Interfaces 27(1): 53-70.
Elliot S, Harris A. The methodology of cost effectiveness analysis: avoiding common pitfalls. Medical Journal of Australia 166(12):636-639.
Hailey D. Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies. Social Science and Medicine 45(4):563-581.
Harris A, Clark R, Verikios G. Cost effectiveness versus cost benefit analysis in road safety interventions. Accident Analysis and Prevention.
Jackson T, Sevil P. Problems in counting and paying for multidisciplinary outpatient clinics. Australian Health Review 20(3):38-54.
Olsen J. Aiding priority setting in health care: is there a role for the contingent valuation method? Health Economics 6:603-612.
Olsen J. Theories of justice and their implications for priority setting in health care. Journal of Health Economics 16:625-639.
Pirkis J, Segal L, Dunt D, Orr T, Parsons T, Mossop G. An evaluation of a diabetes 'shared care' program in a rural division of general practice. Journal of Primary Health Care Interchange 3:26-35.
Richardson J, Nord E. The importance of perspective in the measure of quality adjusted life years. Medical Decision Making 17:33-41.
Robertson I, Ball M. Is there an effect of menopause on CHD mortality - Asia Pacific comparisons. Asia Pacific Journal of Clinical Nutrition 6(3):226-228.
Solin M, Ball M, Robertson I, deSilva A, Pasco J, Kotowicz M, Nicholson G, Collier G. Relationship of serum leptin to total and truncal body fat. Clinical Science 93:581-584.
1996
CART-Project-Team. Developing methodologies for evaluating community-wide health promotion. Health Promotion International 11(3):227-236.
Coast R, Smith R, Millar M. Super-bugs: should antimicrobial resistance be included as a cost in economic evaluation? Health Economics 5(3):217-226.
Hailey D. Developments and outcomes in Australian diagnostic imaging services. Academic Radiology 3(Supplement 1):S92-S94.
Hailey D. Health technology assessment in Australia: a need to refocus. Journal of Quality in Clinical Practice 16:123-129.
Hailey D. International health technology assessment meetings. Journal of Quality in Clinical Practice 16:61-63.
Hailey D. Prostate cancer raises doubts about screening. Diagnostic Imaging International (April/May):33-34,39-40.
Hailey D, Kevles BA. Debate intensifies over the value of breast cancer screening. Diagnostic Imaging International 12:19-25, 27.
Harris E, Richardson J, Farish S, Saltman D. The reliability and validity of physician work measurements in Australian general practice office consultations. Medical Journal of Australia 65(July):18-21.
Jackson T. A proposal for managed care payment options for patients with chronic conditions. Australian Health Review 19 (1).
Marshall D, Hailey D, Jonsson E. Health policy on bone density measurement technology in Sweden and Australia. Health Policy 35:217-228.
McKie J, Kuhse H, Richardson J, Singer P. Allocating health care by QALYs: the relevance of age. Cambridge Quarterly of Healthcare Ethics 5(4):534-545.
McKie J, Kuhse H, Richardson J, Singer P. Another peep behind the veil. Journal of Medical Ethics 22(4):216-221.
McKie J, Kuhse H, Richardson J, Singer P. Double jeopardy: the equal value of life and the veil of ignorance. Journal of Medical Ethics 22 (4): 204-208.
Montalto M, Dunt D, Richardson J. Differences in patient throughput between community health centres and general practitioners. Australian Health Review 19(3):56-65.
Richardson J, Hall J, Salkeld G. The measurement of utility in multiphase health states. International Journal of Technology Assessment in Health Care 12(1):151-162.
Sanson-Fisher R, Redman S, Carter R. Developing methodologies for evaluating community wide health promotion. Health Promotion International 11(3):227-236.
Selby Smith C, Crowley S. An employment profile of allied health professions in Australia: challenges for the 90's and beyond. Journal of Allied Health (Fall):249-265.
Smith R. Is regret theory an alternative basis for estimating the value of healthcare interventions? Health Policy 37(2):105-115.
Smith R, Coast J, Millar M. Over-the-counter antimicrobials: the hidden costs of resistance. Journal of Antimicrobial Chemotherapy 37:1031-1032.
Wood C, Maher P, O'Callaghan D, Hailey D, Downing B. Underutilization of laparoscopic oophorectomy. The Australian and New Zealand Journal of Obstetrics & Gynaecology 36(2):198-201.
1995
Costello A, Crowe H, Jackson T, Street A. A randomised single institution study comparing laser prostatectomy and transurethral resection of the prostate. Annals Academy of Medicine, Singapore 24(5):700-704.
Jackson T. Casemix: the building blocks. Australian Health Review 18(1):105-116.
Jackson T, Street A, Costello A, Crowe H. Cost effectiveness of laser ablation of the prostate: premature evaluation. International Journal of Technology Assessment in Health Care 11(3):595-610.
Montalto M, Adams G, Dunt D, Street A. The true believers study: differences in work activities between private and community health centre general practitioners. Medical Journal of Australia 163:187-190.
Nord E, Richardson J, Street A, Kuhse H, Singer P. Maximising health benefits versus egalitarianism: an Australian survey of health issues. Social Science and Medicine 41(10):1429-1437.
Nord E, Richardson J, Street A, Kuhse H, Singer P. Who cares about cost: does economic analysis impose or reflect social values." Health Policy 34 : 79-94.
Nord E, Street A, Richardson J. The significance of age and duration of effect in social evaluation of health care. Health Care Analysis 4:103-111.
Richardson J. Medicare: radical reform or incrementalism. Australian Health Review 18(1):2-8.
Richardson J, Crowley S. The case for alcohol taxation in Australia. Drug and Alcohol Review 14:89-99.
Scotton R. Managed competition: issues for Australia. Australian Health Review 18(1):82-104.
Selby Smith C, Crowley S. Labour force planning issues for allied health in Australia. Journal of Allied Health (Fall):249-265.
Singer P, McKie J, Kuhse H, Richardson J. Double jeopardy and the use of QALYs in health care allocation. Journal of Medical Ethics 21:114-150.
1994
Bower C, Condon R, Payne J, Hendrie D, Harris A, Henderson R. Sequelae of Haemophilus Influenza Type B Meningitis in children under 5 years of age. Journal of Paediatrics and Child Health 30:393-397.
Carter R. A macro approach to economic appraisal in the health sector. The Australian Economic Review 2nd Quarter (106): 105-112.
Cook J, Richardson J, Street A. A cost utility analysis of treatment options for gallstone disease: methodological issues and results. Health Economics 3:157-168.
Costello A, Jackson T, Crowe H, Street A. Comment and reply: Transurethral resection of the prostate. Australian New Zealand Journal of Surgery 64:795.
Geelhoed E, Harris A, Prince R. Cost effectiveness of hormone therapy and lifestyle interventions for hip fracture. Australian Journal of Public Health 18(2):153-159.
Harris A. Economic appraisal in the regulation of pharmaceuticals in Australia: its rational and potential impact. Australian Economic Review 2:99-104.
Harris A, Bower C, Hendrie D. An economic appraisal of the PRP-OMP vaccine for Haemophilus Influenza Type B disease. Medical Journal of Australia 160:464-483.
Harris E, Richardson J. Pressure for health care reform. Medical Journal of Australia 160(8):463-464.
Hendrie D, Rosman D, Harris A. The hospital costs of road crashes in Western Australia. Australian Journal of Public Health 18(4).
Richardson J. Cost utility analysis: what should be measured. Social Science and Medicine 39(1):7-21.
Richardson J. Medicare: policy issues and options. The Australian Economic Review (2nd Quarter):73-80.
Richardson J, Crowley S. Optimal alcohol taxation: balancing external and consumption costs. Health Economics 3:73-77.
Richardson J, Schwartz S, Glasziou P. QALYs for resource allocation: a reply to Burrows and Brown. Australian Journal of Public Health 17(4):394-396.
Scotton R. Lets think seriously about managed competition. Social Science and Medicine 38(2):v-vii.
Segal L, Carter R, Zimmet P. The cost of obesity: the Australian perspective. Pharmaco-Economics 5(Supplement 1):45-52.
Segal L, Richardson J. Economic framework for allocative efficiency in the health sector. The Australian Economic Review (2nd Quarter):89-97.
Selby Smith C, Crowley S. Health labour force planning for allied health. The Australian perspective. Journal of Allied Health.
Selby Smith C, Hailey D, Drummond M. The role of economic appraisal in health technology assessment: the Australian case. Social Science in Medicine 38:1653-1662.
Sintonen H. Outcome measurement in acid-related diseases. Pharmaco-Economics 5(Supplement 3):17-26.
Weerasooriya H, Murdock C, Harris A, Davis M. The cost effectiveness of treatment of Supraventricular Arrythmias related to an accessory atrioventricular pathway: comparison of catheter ablation, surgical division and medical treatment. Australian and New Zealand Journal of Medicine 24(2):161.
Whitworth J, Jackson T. Consensus statement on the management of hypertension. Medical Journal of Australia 160(Special Supplement No 6).
1993
Burrows C, Brown K. QALYs for resource allocation: probably not and certainly not yet. Australian Journal of Public Health 17:278-286.
Burrows C, Brown K, Gruskin A. Who buys health insurance: a survey of two large organizations. Australian Journal of Social Issues 28:106-123.
Carter R, Glasziou P, Oortmarssen G, et al. Cost-effectiveness of mammographic screening in Australia. Australian Journal of Public Health 17(1):42-50.
Duckett S, Jackson T. Casemix classification for outpatient services based on episodes of care. Medical Journal of Australia 158(7):489-492.
Hailey D, Lea A, Dunt D. Measuring blood cholesterol. Letter to Australian Journal of Public Health 15(6):310-311.
Herrman H, Singh B, Schofield H, Eastwood R, Burgess P, Lewis V, Scotton R. The health and wellbeing of informal caregivers: a review and study program. Australian Journal of Public Health 17(3):261-266.
Nord E, Richardson J, Macarounas-Kirchmann K. Social evaluation of health care versus personal evaluation of health States: evidence on the validity of four health State scaling instruments using Norwegian and Australian survey data. International Journal of Technology Assessment in Health Care 9:463-478.
Richardson J. Bulk billing of general practitioner services: the evidence. Australian Journal of Public Health 17(1):74-75.
Richardson J. Bulk billing of general practitioner services: the evidence: commentary on Rosenman and McKinnon. Australian Journal of Public Health 17(1):74.
Richardson J. Medicare: condition satisfactory. New Doctor 59(Summer):14-18.
Richardson J, Schwartz S, Glasziou P. QALYs for resource allocation. A reply to Burrows and Brown. Australian Journal of Public Health 17(4).
Schwartz S, Richardson J, Glasziou P. Quality adjusted life years: origins, measurements, applications, objections. Australian Journal of Public Health 17(3):272-277.
1992
Brown K, Burrows C. A prospective cost-effectiveness study of alternative work-up strategies in colorectal cancer screening. Australian Health Review 15(2):176-189.
Burrows C, Brown K. Are any numbers better than no numbers? The sorry state of willingness-to-pay and some major methodological shortcomings. Australian Health Review 15(2):135-144.
Hall J, Gerard K, Salkeld S, Richardson J. Cost utility analysis of mammography screening in Australia. Social Science and Medicine (34):9.
O'Connor R. Health related quality of life measures need content validity. Australian Health Review 15(2):S155-163.
Richardson J, Cook J. Cost utility analysis: new directions in setting health care priorities. Australian Health Review 15(2):145-154.
Richardson J, Cook J. The QALY: victim of misinformation. Health Issues (September):24-26.
Selby Smith C. Health economics and policy: problems and prescriptions by Malcolm C. Brown: a review. Australian Health Review 15(2):228-229.
Selby Smith C, Dunt D. Work program of the National Centre for Health Program Evaluation. Australian Health Review 15(2):117-123.
Shelley J, Street A. Increasing women's participation in Pap smear screening in Australia - how can we tell if the national policy is effective? Australian Health Review 15(2):190-199.
Street A. Are QALYs equiable? Commentary on Hall J, in 'Economics and Health 1991: Proceedings of the Thirteenth Australian Conference of Health Economists' .
Street A, Richardson J. The value of health care: what can we learn from Oregon? Australian Health Review 15(2):124-134.
1991
Altman S, Jackson T. Health care in Australia: lessons from down under. Health Affairs 10(3 - Fall):129-144.
Jackson T. Ambulatory casemix in Australia. Australian Health Review 14(3):335-345.
Richardson J. Alcohol consumption in Australia: the economic cost and policy implications. Medical Journal of Australia 154:842-844.
Richardson J. Economic assessment of health care: theory and practice. Australian Economic Review 1:4-21.
Richardson J. Is eight percent of GDP enough: the future direction of Australia's health care system. Australian Quarterly (Summer):314-336.
Richardson J. Medical remuneration. New Doctor 53(Winter):17-22.
Selby Smith C. The social sciences of health research by J. Daly and E. Willis: a review. Australian Health Review 14(4):475-477.
1990
Brown K, Burrows C. The sixth stool guaiac test: $47 million that never was. Journal of Health Economics 9:429-445.
Richardson J. Alcohol taxes: the case for reform. Medical Journal of Australia 152:12.
|
